Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions

Oncology Reports

Volumn 12, Issue 4, 2004, Pages 789-795

  Daido, Shigeru ^a   Takao, Soichiro ^a   Tamiya, Takashi ^a   Ono, Yasuhiro ^a   Terada, Kinya ^a   Ito, Sachio ^a   Ouchida, Mamoru ^a   Date, Isao ^a   Ohmoto, Takashi ^a   Shimizu, Kenji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Allelic loss; Chromosome 10; Glioma; Prognosis; Tumor suppressor gene

Indexed keywords

DNA; MICROSATELLITE DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CHILD; CHROMOSOME 10; COMPARATIVE STUDY; FEMALE; GENETICS; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 10; DNA, NEOPLASM; FEMALE; GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PROGNOSIS;

EID: 16644376059     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.4.789     Document Type: Article

References (35)

1. Report of the Medical Research Council Brain Tumour Working Party: Prognostic factors for high-grade malignant glioma: development of a prognostic index. J Neuro-Oncol 9: 47-55, 1990.
2. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS and Tsukada Y: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A Joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group Study. Cancer 52: 997-1007, 1983. (Pubitemid 13050763)
3. Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K and Louis DN: Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher KI-67 proliferation indices. J Neuropathol Exp Neurol 55: 1026-1031, 1996. (Pubitemid 26338014)
4. Ono Y, Tamiya T, Ichikawa T, Matsumoto K, Furuta T, Ohmoto T, Akiyama K, Seki S, Ueki K and Louis DN: Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression. Acta Neuropathol 94: 21-27, 1997. (Pubitemid 27289098)
5. Mizumatsu S, Tamiya T, Ono Y, Abe T, Matsumoto K, Furuta T and Ohmoto T: Expression of cell-cycle regulator p27Kip1 correlates with survival in patients with astrocytoma. Clin Cancer Res 5: 551-557, 1999. (Pubitemid 29131964)
6. Terada K, Tamiya T, Daido S, Kambara H, Tanaka H, Ono Y, Matsumoto K, Ito S, Ouchida M, Ohmoto T and Shimizu K: Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas. J Neuro-Oncol 58: 107-114, 2002. (Pubitemid 34784840)
7. Louis DN and Gusella JF: A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet 11: 412-415, 1995.
8. Collins VP: Progression as exemplified by human astrocytic tumors. Semin Cancer Biol 9: 267-276, 1999.
9. Weber RG, Sabel M, Reifenberger J, Sommer C, Oberstrass J, Reifenberger G, Kiessling M and Cremer T: Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13: 983-994, 1996. (Pubitemid 26329085)
10. Bigner SH, Burger PC, Wong AJ, Werner MH, Hamilton SR, Muhlbaier LH, Vogelstein B and Bigner DD: Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J Neuropafhol Exp Neurol 47: 191-205, 1988.
11. Von Deimling A, Louis DN and Wiestler OD: Molecular pathways in the formation of gliomas. Glia 15: 328-338, 1995.
12. Rasheed BKA, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD and Bigner SH: Alterations of the TP53 gene in human gliomas. Cancer Res 54: 1324-1330, 1994. (Pubitemid 24108076)
13. Leenstra S, Oscam NT, Buleveld EH, Bosch DA, Troost D and Hulsebos TJM: Genetic subtype of human malignant astrocytoma correlate with survival. Int J Cancer 9: 159-165, 1998. (Pubitemid 28201688)
14. Ino Y, Zlatescu MC, Sasaki H, MacDonald DR, Stemmer-Rachamimov AO, Jhung S, Ramsay DA, von Deimling A, Louis DN and Cairncross JG: Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome lp loss. J Neurosurg 92: 983-990, 2000. (Pubitemid 30346517)
15. Bigner SH, Mark J and Bigner DD: Cytogenetics of human brain tumours. Cancer Genet Cytogenet 47: 141-154, 1990.
16. Ichimura K, Schmidt EE, Miyakawa A, Goike HM and Collins VP: Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades. Genes Chromosomes Cancer 22: 9-15, 1998. (Pubitemid 28217801)
17. Albarosa R, Colombo BM, Roz L, Magnani I, Pollo B, Cirenei N, Giani C, Conti AM, DiDonato S and Finocchiaro G: Deletion mapping of gliomas suggests the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q. Am J Hum Genet 58: 1260-1267, 1996. (Pubitemid 26153838)
18. Belesaria S, Brock C, Bower M, Clark J, Nicholson SK, Lewis P, Sanctis S, Evans H, Peterson D, Mendoza N, Glaser MG, Newlands ES and Fisher RA: Loss of chromosome 10 is an independent prognostic factor in high grade gliomas. Br J Cancer 81: 1371-1377, 1999.
19. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997. (Pubitemid 27148818)
20. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, Deimling A and Poustka A: DMBT1, and new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumors. Nat Genet 17: 32-39, 1997. (Pubitemid 27377529)
21. Steck PA, Perhouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langfold LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF and Tavtigian SV: Identification of a candidate tumor suppressor gene at 10q23.3 that is mutated in multiple advanced cancers, MMAC-1. Nat Genet 15: 356-363, 1997.
22. Chernova OB, Sommerville RPT and Cowell JK: A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 17: 2873-2881, 1998. (Pubitemid 29010057)
23. Nakamura H, Yoshida M, Tsuiki H, Ito K, Ueno M, Nakao M, Oka K, Tada M, Kochi M, Kuratsu J, Ushio Y and Saya H: Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region. Oncogene 16: 1009-1019, 1998. (Pubitemid 28107939)
24. Weshsler DS, Shelly CA, Petroff CA and Dang CV: MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. Cancer Res 57: 4905-4912, 1997. (Pubitemid 27469001)
25. Yamaguchi F, Saya H, Bruner J M and Morrison RS: Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci USA 91: 484-488, 1994. (Pubitemid 24041426)
26. Kleihues P and Cavenee WK (eds): World Health Organization classification of tumours: Pathology and genetics of tumours of the nervous system. IARC Press, Lyon, 2000.
27. Lin H, Bondy ML, Langford LA, Hess KR, Delclos GL, Wu X, Cha W, Pershouse MA, Yung WKA and Steck PA: Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance. Clin Cancer Res 4: 2447-2454, 1998. (Pubitemid 28477911)
28. Kimmelman AC, Ross DA and Liang BC: Loss of heterozygosity of chromosome lOp in human glioblastomas. Genomics 34: 250-254, 1996. (Pubitemid 26172852)
29. Wu W, Kemp BL, Proctor ML, Gazdar AF, Minna JD, Hong WK and Mao L: Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Res 59: 1846-1851, 1999. (Pubitemid 29186155)
30. Tada K, Shiraishi S, Kamiryo T, Nakamura H, Hirano H, Kuratsu J, Kochi M, Saya H and Ushio Y: Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival. J Neurosurg 95: 651-659, 2001. (Pubitemid 33031427)
31. Leenstra S, Bijlsma EK, Troost D, Oosting J, Westerveld A, Bosch DA and Hulsebos TJ: Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis. Br J Cancer 70: 684-689, 1994.
32. Kunapuli P, Chitta KS and Cowell JK: Suppression of the cell proliferation and invasion phenotypes in glioma cells by the LGI1 gene. Oncogene 22: 3985-3991, 2003. (Pubitemid 36819638)
33. Steck PA, Lin H, Langford LA, Jasser SA, Koul D, Yung WKA and Pershouse MA: Functional and molecular analyses of 10q deletions in human gliomas. Genes Chromosomes Cancer 24: 135-143, 1999. (Pubitemid 29025259)
34. Stone DM, Murone M, Luoh SM, Ye W, Armanini MP, Gurney A, Phillips H, Brush J, Goddard A, deSauvage FJ and Rosenthal A: Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli. J Cell Sci 112: 4437-4448, 1999. (Pubitemid 30122035)
35. Taylor MD, Liu L, Raffel C, Hui C, Mainprize TG, Zhang X, Agatep R, Chiappa S, Gao L, Lowrance A, Hao A, Goldstein AM, Stavrou T, Scherer SW, Dura WT, Wainwright B, Squire JA, Rutka JT and Hogg D: Mutations in SUFU predispose to medulloblastoma. Nat Genet 31: 306-310, 2002.